Sound waves plus drug may slow aggressive brain tumor return
NCT ID NCT06496971
First seen Apr 12, 2026 · Last updated May 14, 2026 · Updated 5 times
Summary
This study tests whether adding focused ultrasound (NaviFUS) to the standard drug Avastin can help people with recurrent glioblastoma, a serious brain cancer. About 32 adults whose tumor has come back after prior treatment will be randomly assigned to get Avastin alone or Avastin plus ultrasound. The main goal is to see if the combination keeps the cancer from growing longer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Linkou Chang Gung Memorial Hospital
RECRUITINGTaoyuan, 33305, Taiwan
Contact Email: •••••@•••••
-
National Taiwan University Hospital
RECRUITINGTaipei, 10048, Taiwan
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.